BPLEX vs. CLS

Last updated Jun 10, 2026

BPLEX (Boston Partners Long/Short Equity Fund) is Long-Short fund managed by Boston Partners, while CLS (Celestica Inc.) is a stock. Over the past 10 years, BPLEX returned 13.44%/yr vs 42.61%/yr for CLS. At a 0.23 correlation, their price movements are largely independent.

Performance

BPLEX vs. CLS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Boston Partners Long/Short Equity Fund (BPLEX) and Celestica Inc. (CLS). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BPLEX achieves a 11.10% return, which is significantly lower than CLS's 25.79% return. Over the past 10 years, BPLEX has underperformed CLS with an annualized return of 13.44%, while CLS has yielded a comparatively higher 42.61% annualized return.

BPLEX

• 1D: 0.09%
• 1M: 0.17%
• YTD: 11.10%
• 6M: 14.03%
• 1Y: 29.48%
• 3Y*: 35.96%
• 5Y*: 24.30%
• 10Y*: 13.44%

CLS

• 1D: -3.79%
• 1M: -0.98%
• YTD: 25.79%
• 6M: 8.72%
• 1Y: 203.19%
• 3Y*: 205.59%
• 5Y*: 113.26%
• 10Y*: 42.61%

*Multi-year figures are annualized to reflect compound growth (CAGR)

BPLEX vs. CLS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
BPLEX Boston Partners Long/Short Equity Fund	11.10%	27.87%	56.97%	14.93%	6.95%	31.73%	-5.82%	8.97%	-15.70%	2.54%
CLS Celestica Inc.	25.79%	220.27%	215.23%	159.80%	1.26%	37.92%	-2.42%	-5.70%	-16.32%	-11.56%

Correlation

The correlation between BPLEX and CLS is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.31
Correlation (3Y) Calculated over the trailing 3-year period	0.36
Correlation (5Y) Calculated over the trailing 5-year period	0.44
Correlation (10Y) Calculated over the trailing 10-year period	0.41
Correlation (All Time) Calculated using the full available price history since Nov 16, 1998	0.23

The correlation between BPLEX and CLS shifts across timeframes, from 0.23 (all time) to 0.44 (5 years), reflecting how their relationship changes across market environments.

Return for Risk

BPLEX vs. CLS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BPLEX

BPLEX Risk / Return Rank: 93
BPLEX Sharpe Ratio Rank: 94
BPLEX Sortino Ratio Rank: 94
BPLEX Omega Ratio Rank: 86
BPLEX Calmar Ratio Rank: 96
BPLEX Martin Ratio Rank: 95

CLS

CLS Risk / Return Rank: 92
CLS Sharpe Ratio Rank: 95
CLS Sortino Ratio Rank: 88
CLS Omega Ratio Rank: 88
CLS Calmar Ratio Rank: 96
CLS Martin Ratio Rank: 95

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BPLEX vs. CLS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Boston Partners Long/Short Equity Fund (BPLEX) and Celestica Inc. (CLS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BPLEX	CLS	Difference
Sharpe ratio: Return per unit of total volatility	2.87	2.82	+0.05
Sortino ratio: Return per unit of downside risk	4.45	2.82	+1.63
Omega ratio: Gain probability vs. loss probability	1.52	1.37	+0.15
Calmar ratio: Return relative to maximum drawdown	5.66	7.00	-1.34
Martin ratio: Return relative to average drawdown	20.36	17.31	+3.04
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BPLEX vs. CLS - Sharpe Ratio Comparison

The current BPLEX Sharpe Ratio is 2.87, which is comparable to the CLS Sharpe Ratio of 2.82. The chart below compares the historical Sharpe Ratios of BPLEX and CLS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	BPLEX	CLS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.87	2.82	+0.05
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.64	1.98	-1.33
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.46	0.86	-0.40
Sharpe Ratio (All Time) Calculated using the full available price history	0.55	0.27	+0.28

Drawdowns

BPLEX vs. CLS - Drawdown Comparison

The maximum BPLEX drawdown since its inception was -43.47%, smaller than the maximum CLS drawdown of -96.93%. Use the drawdown chart below to compare losses from any high point for BPLEX and CLS.

Drawdown Indicators

	BPLEX	CLS	Difference
Max Drawdown Largest peak-to-trough decline	-43.47%	-96.93%	+53.46%
Max Drawdown (1Y) Largest decline over 1 year	-5.23%	-29.24%	+24.01%
Max Drawdown (3Y) Largest decline over 3 years	-28.78%	-53.96%	+25.18%
Max Drawdown (5Y) Largest decline over 5 years	-28.78%	-53.96%	+25.18%
Max Drawdown (10Y) Largest decline over 10 years	-37.65%	-80.60%	+42.95%
Current Drawdown Current decline from peak	-0.43%	-21.28%	+20.85%
Average Drawdown Average peak-to-trough decline	-6.61%	-73.34%	+66.73%
Ulcer Index Depth and duration of drawdowns from previous peaks	1.45%	11.79%	-10.34%

Volatility

BPLEX vs. CLS - Volatility Comparison

The current volatility for Boston Partners Long/Short Equity Fund (BPLEX) is 3.82%, while Celestica Inc. (CLS) has a volatility of 26.77%. This indicates that BPLEX experiences smaller price fluctuations and is considered to be less risky than CLS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BPLEX	CLS	Difference
Volatility (1M) Calculated over the trailing 1-month period	3.82%	26.77%	-22.95%
Volatility (6M) Calculated over the trailing 6-month period	8.26%	55.22%	-46.96%
Volatility (1Y) Calculated over the trailing 1-year period	10.34%	72.51%	-62.17%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	37.92%	57.65%	-19.73%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	29.30%	49.94%	-20.64%

Dividends

BPLEX vs. CLS - Dividend Comparison

BPLEX's dividend yield for the trailing twelve months is around 9.85%, while CLS has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BPLEX Boston Partners Long/Short Equity Fund	9.85%	10.94%	58.72%	28.35%	15.19%	5.11%	44.84%	11.33%	9.69%	0.83%	0.00%	9.91%
CLS Celestica Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both BPLEX and CLS in my portfolio?

BPLEX and CLS have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BPLEX or CLS?

CLS has higher volatility (26.77%) compared to BPLEX (3.82%). In terms of maximum drawdown, BPLEX dropped -43.47% vs CLS's -96.93%.

Which has better risk-adjusted returns?

BPLEX currently has the higher Sharpe Ratio (2.87 vs 2.82), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.